Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ulcerative colitis
Biotech
Bourla says pipeline pruning is mostly done after 6 more culls
Pfizer's CEO said he expects to add more programs to the pharma's plate by harnessing the power of AI.
Darren Incorvaia
Feb 3, 2026 11:33am
Sanofi keeps mum on Denali pact after scrapping final RIPK1 drug
Jan 29, 2026 5:16am
Ose narrows focus to conserve cash at expense of wider pipeline
Dec 9, 2025 9:41am
AnaptysBio abandons rosnilimab for UC after phase 2 fail
Nov 10, 2025 10:05am
Odyssey saga continues with $213M series D
Sep 10, 2025 8:00am
Vedanta's live bacteria cocktail fails phase 2 colitis trial
Aug 13, 2025 1:48pm
